Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 11:15:142-162.
doi: 10.1017/bca.2024.16.

Valuing a Reduction in the Risk of Chronic Kidney Disease: A Large-Scale Multi-Country Stated Preference Approach

Chris Dockins  1 , Damien Dussaux  2 , Charles Griffiths  1 , Sandra Hoffmann  3 , Nathalie Simon  1
Affiliations

Valuing a Reduction in the Risk of Chronic Kidney Disease: A Large-Scale Multi-Country Stated Preference Approach

Chris Dockins et al. J Benefit Cost Anal. .

Abstract

Compromised kidney function is associated with an array of environmental contaminants and pathogens that may be considered for regulation. However, there are few valuation estimates for kidney effects for use in benefit-cost analyses, particularly willingness-to-pay estimates. This paper is one of several surveys valuing morbidity developed by the OECD Surveys to elicit Willingness-to-pay to Avoid Chemicals-related negative Health Effects project, which aims to improve the basis for benefit-cost analyses. We report the results of a stated preference survey valuing reduced the risk of symptomatic chronic kidney disease, filling an important gap in the valuation literature and addressing a need for applied benefits analysis of chemical regulation. The survey was administered to representative samples in each of 10 countries: Canada, Chile, China, Denmark, Germany, Italy, Norway, Türkiye, the United Kingdom, and the United States. The mean (median) WTP for an average reduction of 3.5 in 1,000 of the risk of serious kidney disease over 5 years is $2,609 ($764), corresponding to a mean (median) value per statistical case (VSC) of chronic kidney disease of $805,000 ($224,000). The mean VSC varies between $700,000 for Canada and $1,200,000 for Türkiye.

Keywords: D61; I18; J17; K32; Q51; Q53; Q58; health risk; health valuation; kidney disease; stated preference; willingness-to-pay.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Sample WTP question.
See this image and copyright information in PMC

References

    1. Cameron Trudy Ann. 2014. “Valuing Morbidity in Environmental Benefit-Cost Analysis.” Annual Review of Resource Economics, 6(1): 249–272.
    1. Carson Richard and Hanneman Michael (2006), “Contingent Valuation.” In Mäler KG and Vincent Jeffrey (Eds.) The Handbook of Environmental Economics, Vol. 2, 821–936. Amsterdam: Elsevier.
    1. Carthy Trevor, Chilton Susan, Covey Judith, Hopkins Lorraine, Michael Jones-Lee Graham Loomes, Pidgeon Nick, and Spencer Anne. 1998. “The Contingent Valuation of Safety and the Safety of Contingent Valuation: Part 2-The CV/SG “Chained” Approach.” Journal of Risk and Uncertainty, 17(3): 187–213.
    1. Dockins Chris, Dussaux Damien, Griffiths Charles, Hoffmann Sandra and Simon Nathalie. 2023. “Valuing a Reduction in the Risk of Chronic Kidney Disease: A Large Scale Multi-Country Stated Preference Approach.” OECD Environment Working Papers, No. 216. - PMC - PubMed
    1. ECHA. 2014. “Stated-Preference Study to Examine the Economic Value of Benefits of Avoiding Selected Adverse Human Health Outcomes Due to Exposure to Chemicals in the European Union – Part I: Sensitisation and Dose Toxicity.” http://echa.europa.eu/documents/10162/13630/study_economic_benefits_avoi....

LinkOut - more resources